Related Experiment Video
Updated: Jun 17, 2026

An In vitro Model to Study Immune Responses of Human Peripheral Blood Mononuclear Cells to Human Respiratory Syncytial Virus Infection
Published on: December 10, 2013
[Effect of an active component from Forsythia suspensa (Thunb.) Vahl against respiratory syncytial virus in vitro]
Yang Chen1, Xin Li, Jing-Yu Zhou
1Public Health College of Harbin Medical University, Harbin 150081, China.
Objective:
To study the extraction of an active component LC-4 from Forsythia suspensa (Thunb.) Vahl and anti-respiratory syncytial virus (RSV) effect in vitro.
Methods:
The extration from boiling water of Forsythia suspensa were extracted by hot water extraction and were precipitated by ethanol and were elicited by macroporous adsorptive resins column chromatography. Then the antiviral active component LC-4 was separated from the production by eluting. The cytotoxicities and antiviral effect of LC-4 were tested by the Neutral Red assay and the cytopathic effect (CPE) inhibition assay. Ribavirin was used as the positive drug in the study. The antiviral effect of prevention and treatment of maximum dose of non-cytotoxicity of LC-4 was tested in Hela cell line.
Results:
LC-4 showed that the concentration were 25.4 microg/ml with the medium cytotoxicity and were 2.11 microg/ml with the medium effective concentration (EC50). The corresponding treatment index of LC-4 was 12.04. It also exhibited obviously inhibition effect on RSV replications when LC-4 was added at 2 h, 4 h, 6 h and 8 h after infection (P < 0.05). The CPE was significant difference in comparison with control group, when the concentration of LC-4 between 31.25 microg/ml and 3.91 microg/ml was added at 2 h before infection (P < 0.05).
Conclusion:
LC-4 could significantly prevent and inhibit RSV replications in vitro.
Related Concept Videos
Respiratory Syncytial Virus Disease
Upper Respiratory Drugs: Antitussives, Expectorants, and Mucolytics
Antitussives include codeine, dextromethorphan (Robitussin), and benzonatate (Tessalon). Codeine and dextromethorphan exert their effects centrally by suppressing the cough reflex center in the medulla. Benzonatate operates peripherally within the respiratory tract by anesthetizing...
Inhibitors Of Virion Release
Drugs Used in Upper Respiratory Disorders: Overview
Antihistamines (e.g., Benadryl) block histamines from binding. Histamines are chemicals released during an allergic reaction in the body. As a...
Drugs Used in Lower Respiratory Disorders: Overview
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
Inhibitors of Virion Maturation and Assembly

